Dupilumab Therapy for EGIDs — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dupilumab Therapy for EGIDs — Stella

Home/Eosinophilic Gastrointestinal Disorders (EGIDs)/

View on ClinicalTrials.gov

Recruiting

Back to Eosinophilic Gastrointestinal Disorders (EGIDs) trials

Trial locations(1 site)

China

201102, Shanghai

Key details

Sponsor

Children's Hospital of Fudan University

Enrollment target

~20 participants

Started

January 2025

Primary completion

January 2027

Age range

1 Year – 18 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.